Gynae – Oncology Regimen Protocols

Blank Chemotherapy Prescriptions

Included are blank Chemocare regimen specific prescription files to be used as a part of local Trust contingency plan if the Chemocare Network Systems are not available.

Network Chemocare Blank Gynae Prescription templates zip folder click here. Last updated 03.01.2018.

Chemotherapy Protocols

The documents below are Northern Cancer Alliance (NCA) approved protocols for the management of patients receiving chemotherapy for Gynaecological Cancers.  All prescribing, preparation, dispensing and administration of chemotherapy should be within a framework of safe practice.

DISCLAIMER: The protocols on this website are for local guidance only, their accuracy cannot be guaranteed, please refer the SPC for information on the individual products.  There are a number of protocols that are past their expiry/ review date.   These are retained on the website for information only following requests from local Trusts, they must only be used on the understanding the responsibility for the use lies with local organisation and not NCA.  NCA cannot accept responsibility for the validity of content of any documents that are past the review date.

No Regime Name Valid Until Protocol
GY002 Carboplatin September 2021 Download
GY003 Paclitaxel September 2021 Download
GY005 Rotterdam Regimen (Cisplatin and Etoposide) September 2021 Download
GY016 Bevacizumab with carboplatin and paclitaxel (1st line Ovarian) September 2021 Download
LO14 Carboplatin and paclitaxel March 2021 Download
GY017 Bevacizumab with carboplatin and Paclitaxel (Cervical cancer) September 2021 Download
GY018 Olaparib September 2021 Download
GY019 Cisplatin & Topotecan September 2021 Download
GY020 Carboplatin & Caelyx (pegylated doxorubicin) September 2021 Download
Discontinued Documents 
GY001 Docetaxel and Carboplatin May 2016 Download
GY004 Topotecan May 2016 Download
GY006 Oral etoposide May 2016 Download
GY007 Pegylated liposomal doxorubicin (Caelyx) May 2016 Download
NCDF Bevacizumab with carboplatin and Gemcitabine – 2nd line Cervical Cancer June 2016 Download